Google Search
A well-documented Business Plan aids in business funding and it is proven to help businesses grow by 30% faster.
Test Your Business ideas- We clear your doubts on Business concept and validate it properly. Often Businesses fail when the Business Plan is weak.
Market Research & High Industry Demand- We will analyse the Market Potential for optimal Industry Growth.
- Overview
- Stats
- Introduction
- Information
- Contact Us
- Project At A Glance
- Profitability And Net Cash Accruals
- Cost Of Project
- Asssessement Of Working Capital Requirements
- Profitability Ratios, Dscr, Debt Equity
- Break Even Analysis
- Means Of Finance
- Projected Balance Sheet
- Repayment Of Term Loan
- Debt Service Coverage Ratio
- Depreciation Chart
- Projected Pay-Back Period
- Projected Irr
- Company Summary
- Reasons For Buying The Report
- Our Approach
- Table Of Content
- Financial Plan
- Information/ Disclaimer
Active Pharma Ingredients (API) (Cephalexin, Ampicillin Trihydrate, Ibuprofen and Paracetamol)
The Active Pharmaceutical Ingredient (API) is the part of any drug that produces the intended effects. Some drugs, such as combination therapies, have multiple active ingredients to treat different symptoms or act in different ways. Production of APIs has traditionally been done by the pharmaceutical companies themselves in their home countries. But in recent years many corporations have opted to send manufacturing overseas to cut costs. This has caused significant changes to how these drugs are regulated, with more rigorous guidelines and inspections put into place. Cefalexin, is an antibiotic that can treat a number of bacterial infections. It kills gram-positive and some gram-negative bacteria by disrupting the growth of the bacterial cell wall. Cefalexin is a beta-lactam antibiotic within the class of first-generation cephalosporins. It works similarly to other agents within this class, including intravenous cefazolin, but can be taken by mouth. Cefalexin can be used in those who have mild or moderate allergies to penicillin. However, it is not recommended in those with severe penicillin allergies. Ampicillin is an antibiotic used to prevent and treat a number of bacterial infections, such as respiratory tract infections, urinary tract infections, meningitis, salmonellosis, and endocarditis. It may also be used to prevent group B streptococcal infection in newborns. It is used by mouth, by injection into a muscle, or intravenously. Like all antibiotics, it is not useful for the treatment of viral infections. Ampicillin is used to treat infections by many Gram-positive and Gram-negative bacteria. It was the first "broad spectrum" penicillin with activity against Gram-positive bacteria, including Streptococcus pneumoniae, Streptococcus pyogenes, some isolates of Staphylococcus aureus (but not penicillin-resistant or methicillin-resistant strains), Trueperella, and some Enterococcus. Paracetamol (acetaminophen) is a pain reliever and a fever reducer. The exact mechanism of action of is not known. Paracetamol is used to treat many conditions such as headache, muscle aches, arthritis, backache, toothaches, colds, and fevers. It relieves pain in mild arthritis but has no effect on the underlying inflammation and swelling of the joint. Paracetamol is generally safe at recommended doses. The recommended maximum daily dose for an adult is three to four grams. Higher doses may lead to toxicity, including liver failure. Serious skin rashes may rarely occur. It appears to be safe during pregnancy and when breastfeeding. In those with liver disease, it may still be used, but in lower doses. It is classified as a mild analgesic. It does not have significant anti-inflammatory activity. How it works is not entirely clear. Ibuprofen is a medication in the nonsteroidal anti-inflammatory drug (NSAID) class that is used for treating pain, fever, and inflammation. This includes painful menstrual periods, migraines, and rheumatoid arthritis. It may also be used to close a patent ductus arteriosus in a premature baby. It can be used by mouth or intravenously. It typically begins working within an hour India's reliance on pharma ingredient imports has risen over the past few decades due to the higher cost of domestic production, with the price gap reaching as much as 20%-30%, particularly for energy-intensive fermentation-based ingredients used in anti-infectives. Import dependence is more than 90% for some life-saving drugs, including penicillin and ciprofloxacin. India is the seventh largest country in the world and has the second highest population. It has a parliamentary democratic form of government and has abundant natural resources and sufficient oil reserves. The country has a huge skilled, English-speaking, and inexpensive labor force. Its young population and current economic policies have made it one of the largest recipients of FDI in the world. Asia Pacific is expected to be the fastest-growing market over the forecast period. Owing to the availability of affordable labor, major companies in the market are setting up API manufacturing plants in developing countries such as China and India. The global demand of APIs include ageing population, rising expenditures on healthcare, increasing prevalence of lifestyle diseases, etc. Looking forward, the market value is projected to reach US$ 258.8 Billion by 2025, exhibiting a CAGR of 5.6% during 2020-2025. The API market is competitive in nature and is becoming increasingly competitive. Consequently, manufacturers are required to enhance products in order to gain advantage over previously marketed products. The emergence of COVID-19 has brought the world to a standstill. We perceive that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies will help within the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost each sector is anticipated to be impacted by the pandemic. The government also notified a scheme to promote bulk drug parks. For selected parks, financial assistance to the tune of 70 per cent of the project cost of common infrastructure facilities will be provided. In the case of Northeast states and hilly states (Himachal Pradesh, Uttarakhand, Union Territory of Jammu & Kashmir, and Union Territory of Ladakh), financial assistance will be 90 per cent of the project cost. The maximum assistance under the scheme for one bulk Drug Park will be limited to Rs 1,000 crore. The total financial outlay of the scheme is Rs 3,000 crore. Role of Government towards API The coronavirus outbreak disrupting supply of active pharmaceutical ingredients (APIs) and medical devices from China to India, the government has come out with four schemes worth Rs 13,760 crore to encourage manufacturing of bulk drugs and medical devices in the country and their exports. On March 21, the Union Cabinet under the chairmanship of Prime Minister Narendra Modi had approved an expenditure of Rs. 9,940 crore and Rs. 3,820 crore for APIs and medical devices, respectively. The Cabinet also approved a scheme on promotion of bulk drug parks for financing common infrastructure facilities in three bulk drug parks with financial implication of Rs. 3,000 crore for next five years. The government will give grants-in-aid to states with a maximum limit of Rs. 1,000 crore per bulk Drug Park. Parks will have common facilities such as solvent recovery plant, distillation plant, power and steam units, common effluent treatment plant etc. The government further approved production linked incentive (PLI) scheme for promotion of domestic manufacturing of critical KSMs/drug intermediates and APIs in the country with financial implications of Rs. 6,940 crore for next eight years. Financial incentive will be given to eligible manufacturers of identified 53 critical bulk drugs on their incremental sales over the base year (2019-20) for a period of 6 years. Out of 53 identified bulk drugs, 26 are fermentation based bulk drugs and 27 are chemical synthesis based bulk drugs. Rate of incentive will be 20 per cent (of incremental sales value) for fermentation based bulk drugs and 10 per cent for chemical synthesis based bulk drugs. The PLI scheme will lead to expected incremental sales of Rs. 46,400 crore and significant additional employment generation over eight years. The drug industry has welcomed the incentives offered by the government to promote API units in India. Besides APIs, the Cabinet also approved the scheme for promotion of medical device parks in the country in partnership with the states. A maximum grant-in-aid of Rs. 100 crore per park will be provided to the states. It will have financial implications of Rs. 400 crore. The PLI scheme for promoting domestic manufacturing of medical devices will have financial implications of Rs. 3,420 crore for next five years. Medical device is a growing sector and its potential for growth is the highest among all sectors in the healthcare market. It is valued at Rs. 50,026 crore for 2018-19 and is expected to reach to Rs. 86,840 crore by 2021-22. India depends on imports up to an extent of 85 per cent of total domestic demand of medical devices. Union Cabinet scheme on Promotion of Bulk Drug Parks • The scheme on Promotion of Bulk Drug Parks for financing Common Infrastructure Facilities in 3 Bulk Drug Parks with financial implication of Rs. 3,000 crore for next five years. • Production Linked Incentive (PLI) Scheme for promotion of domestic manufacturing of critical KSMs/Drug Intermediates and APIs in the country with financial implications of Rs6,940 crore for next eight years. Details: Promotion of Bulk Drug Parks • Decision is to develop 3 mega Bulk Drug parks in India in partnership with States. • Government of India will give Grants-in-Aid to States with a maximum limit of Rs. 1000 Crore per Bulk Drug Park. • Parks will have common facilities such as solvent recovery plant, distillation plant, power & steam units, common effluent treatment plant etc. • A sum of Rs. 3,000 crore has been approved for this scheme for next 5 years. Production Linked Incentive Scheme • Financial incentive will be given to eligible manufacturers of identified 53 critical bulk drugs on their incremental sales over the base year (2019-20) for a period of 6 years. • Out of 53 identified bulk drugs, 26 are fermentation based bulk drugs and 27 are chemical synthesis based bulk drugs. • Rate of incentive will be 20 % (of incremental sales value) for fermentation based bulk drugs and 10% for chemical synthesis based bulk drugs. • A sum of Rs. 6,940 crore has been approved for next 8 years. Few Indian major players are as under Alpha Remedies Ltd. Ankur Drugs & Pharma Ltd. Aurobindo Pharma Ltd. Cian Healthcare Ltd Cipla Ltd. Dr. Reddy'S Laboratories Ltd. Farmson Pharmaceutical Gujarat Pvt. Ltd. Glaxosmithkline Pharmaceuticals Ltd. Indoco Remedies Ltd. Pan Drugs Ltd. Piramal Enterprises Ltd.
| Plant capacity | Plant & machinery | Working capital | T.C.I | Return | Break even |
|---|---|---|---|---|---|
| Paracetamol: 500 Kgs / day Cephalexin: 500 Kgs / day Ampicillin Trihydrate: 500 Kgs / day Ibuprofen: 500 Kgs / day | Rs 347 lakhs | - | Cost of Project: Rs 1656 lakhs | 36% | 52% |
Introduction
We can provide you detailed project reports on the following topics. Please select the projects of your interests.
Each detailed project reports cover all the aspects of business, from analysing the market, confirming availability of various necessities such as plant & machinery, raw materials to forecasting the financial requirements. The scope of the report includes assessing market potential, negotiating with collaborators, investment decision making, corporate diversification planning etc. in a very planned manner by formulating detailed manufacturing techniques and forecasting financial aspects by estimating the cost of raw material, formulating the cash flow statement, projecting the balance sheet etc.
We also offer self-contained Pre-Investment and Pre-Feasibility Studies, Market Surveys and Studies, Preparation of Techno-Economic Feasibility Reports, Identification and Selection of Plant and Machinery, Manufacturing Process and or Equipment required, General Guidance, Technical and Commercial Counseling for setting up new industrial projects on the following topics.
Many of the engineers, project consultant & industrial consultancy firms in India and worldwide use our project reports as one of the input in doing their analysis.
- One Lac / Lakh / Lakhs is equivalent to one hundred thousand (100,000)
- One Crore is equivalent to ten million (10,000,000)
- T.C.I is Total Capital Investment
- We can modify the project capacity and project cost as per your requirement.
- We can also prepare project report on any subject as per your requirement.
- Caution: The project's cost, capacity and return are subject to change without any notice. Future projects may have different values of project cost, capacity or return.
| COST OF PROJECT | MEANS OF FINANCE | ||||||
|---|---|---|---|---|---|---|---|
| Particulars | Existing | Proposed | Total | Particulars | Existing | Proposed | Total |
| Land & Site Development Exp. | ********** | ********** | ********** | Capital | ********** | ********** | ********** |
| Buildings | ********** | ********** | ********** | Share Premium | ********** | ********** | ********** |
| Plant & Machineries | ********** | ********** | ********** | Other Type Share Capital | ********** | ********** | ********** |
| Motor Vehicles | ********** | ********** | ********** | Reserves & Surplus | ********** | ********** | ********** |
| Office Automation Equipments | ********** | ********** | ********** | Cash Subsidy | ********** | ********** | ********** |
| Technical Knowhow Fees & Exp. | ********** | ********** | ********** | Internal Cash Accruals | ********** | ********** | ********** |
| Franchise & Other Deposits | ********** | ********** | ********** | Long/Medium Term Borrowings | ********** | ********** | ********** |
| Preliminary & Pre-operative Exp | ********** | ********** | ********** | Debentures / Bonds | ********** | ********** | ********** |
| Provision for Contingencies | ********** | ********** | ********** | Unsecured Loans/Deposits | ********** | ********** | ********** |
| Margin Money - Working Capital | ********** | ********** | ********** | ********** | ********** | ********** | ********** |
| Total | ********** | ********** | ********** | Total | ********** | ********** | ********** |
| PARTICULARS | OPERATING YEARS | ||||
|---|---|---|---|---|---|
| 1-2 | 2-3 | 3-4 | 4-5 | 5-6 | |
| ********** | ********** | ********** | ********** | ********** | |
| Revenue/Income/Realisation | ********** | ********** | ********** | ********** | ********** |
| Gross Sales Realisation | ********** | ********** | ********** | ********** | ********** |
| Less : Excise Duties/Levies | ********** | ********** | ********** | ********** | ********** |
| Net Sales Realisation | ********** | ********** | ********** | ********** | ********** |
| Total Revenue/Income/Realisation | ********** | ********** | ********** | ********** | ********** |
| ********** | ********** | ********** | ********** | ********** | |
| Expenses/Cost of Products/Services/Items | ********** | ********** | ********** | ********** | ********** |
| Raw Material Cost | ********** | ********** | ********** | ********** | ********** |
| Indigenous | ********** | ********** | ********** | ********** | ********** |
| Total Nett Consumption | ********** | ********** | ********** | ********** | ********** |
| Lab & ETP Chemical Cost | ********** | ********** | ********** | ********** | ********** |
| Packing Material Cost | ********** | ********** | ********** | ********** | ********** |
| Sub Total of Net Consumption | ********** | ********** | ********** | ********** | ********** |
| Miscellaneous Cost | ********** | ********** | ********** | ********** | ********** |
| Employees Expenses | ********** | ********** | ********** | ********** | ********** |
| Fuel Expenses | ********** | ********** | ********** | ********** | ********** |
| Power/Electricity Expenses | ********** | ********** | ********** | ********** | ********** |
| Depreciation | ********** | ********** | ********** | ********** | ********** |
| Royalty & Other Charges | ********** | ********** | ********** | ********** | ********** |
| Repairs & Maintenance Exp. | ********** | ********** | ********** | ********** | ********** |
| Other Mfg. Expenses | ********** | ********** | ********** | ********** | ********** |
| Cost of Output of Goods Sold | ********** | ********** | ********** | ********** | ********** |
| ********** | ********** | ********** | ********** | ********** | |
| Gross Profit | ********** | ********** | ********** | ********** | ********** |
| Administration Expenses | ********** | ********** | ********** | ********** | ********** |
| Technical Knowhow Fees & Exp. | ********** | ********** | ********** | ********** | ********** |
| Financial Charges | ********** | ********** | ********** | ********** | ********** |
| Long/Medium Term Borrowing | ********** | ********** | ********** | ********** | ********** |
| On Wkg. Capital Borrowings | ********** | ********** | ********** | ********** | ********** |
| Total Financial Charges | ********** | ********** | ********** | ********** | ********** |
| Selling Expenses | ********** | ********** | ********** | ********** | ********** |
| Total Cost of Sales | ********** | ********** | ********** | ********** | ********** |
| ********** | ********** | ********** | ********** | ********** | |
| Net Profit Before Taxes | ********** | ********** | ********** | ********** | ********** |
| Tax on Profit | ********** | ********** | ********** | ********** | ********** |
| Net Profit After Taxes | ********** | ********** | ********** | ********** | ********** |
| Depreciation Added Back | ********** | ********** | ********** | ********** | ********** |
| Technical Knowhow Fees & Exp. | ********** | ********** | ********** | ********** | ********** |
| Net Cash Accruals | ********** | ********** | ********** | ********** | ********** |
| PARTICULARS | EXISTING | PROPOSED | TOTAL |
|---|---|---|---|
| COST OF PROJECT | |||
| Land & Site Development Exp. | |||
| Land Area Required | ********** | ********** | ********** |
| Land Development Cost, Boundary Wall, Gate & Road etc. | ********** | ********** | ********** |
| ********** | ********** | ********** | |
| Buildings | ********** | ********** | ********** |
| Factory Building - | ********** | ********** | ********** |
| Office Buildings | ********** | ********** | ********** |
| ********** | ********** | ********** | |
| Plant & Machineries | ********** | ********** | ********** |
| Indigenous Machineries | ********** | ********** | ********** |
| Erection & Installation | ********** | ********** | ********** |
| Laboratory Equipments | ********** | ********** | ********** |
| Miscellaneous Equipments like pumps, valves, pipeline & fittings | ********** | ********** | ********** |
| Imported Machineries | ********** | ********** | ********** |
| Technical know how | ********** | ********** | ********** |
| ********** | ********** | ********** | |
| Office Vehicles | ********** | ********** | ********** |
| Office Automation Equipments (Telephone/ Fax/ Computer) | ********** | ********** | ********** |
| Office Equipment, Furniture plus Other Equipment & Accessories | ********** | ********** | ********** |
| Other Misc. Assets | ********** | ********** | ********** |
| ********** | ********** | ********** | |
| Pre-operative & Preliminary Expenses | ********** | ********** | ********** |
| Provision for Contingencies | ********** | ********** | ********** |
| ********** | ********** | ********** | |
| Total Capital Cost of Project | ********** | ********** | ********** |
| Margin Money for Working Capital | ********** | ********** | ********** |
| Total Cost of Project | ********** | ********** | ********** |
| PARTICULARS | STK.PRD. | STK.PRD. | OPERATING YEARS | |||||
|---|---|---|---|---|---|---|---|---|
| 1st Year | 2nd Yr &+ | 1-2 | 2-3 | 3-4 | 4-5 | 5-6 | ||
| Capacity | Months | Months | % | ********** | ********** | ********** | ********** | ********** |
| CURRENT ASSETS | ********** | ********** | ********** | ********** | ********** | |||
| Stocks on Hand | ********** | ********** | ********** | ********** | ********** | |||
| Raw Material Cost | ********** | ********** | ********** | ********** | ********** | |||
| Indigenous | ********** | ********** | M | ********** | ********** | ********** | ********** | ********** |
| Lab & ETP Chemical | ********** | ********** | M | ********** | ********** | ********** | ********** | ********** |
| Packing Material | ********** | ********** | M | ********** | ********** | ********** | ********** | ********** |
| Consumable Store | ********** | ********** | M | ********** | ********** | ********** | ********** | ********** |
| Work-in-Process | ********** | ********** | D | ********** | ********** | ********** | ********** | ********** |
| Finished Goods | ********** | ********** | M | ********** | ********** | ********** | ********** | ********** |
| Current Expenses | ********** | ********** | M | ********** | ********** | ********** | ********** | ********** |
| Receivables | ********** | ********** | M | ********** | ********** | ********** | ********** | ********** |
| ********** | ********** | ********** | ********** | ********** | ********** | ********** | ||
| Total | ********** | ********** | ********** | ********** | ********** | |||
| Cash/Bank Balances | ********** | ********** | ********** | ********** | ********** | |||
| Gross Wkg. Capital | ********** | ********** | ********** | ********** | ********** | |||
| PARTICULARS | OPERATING YEARS | |||||
|---|---|---|---|---|---|---|
| 1-2 | 2-3 | 3-4 | 4-5 | 5-6 | ||
| Profit Percentages to Net Sales | ||||||
| Gross Profit | ********** | ********** | ********** | ********** | ********** | |
| % Of G.P. to Net Sales | ********** | ********** | ********** | ********** | ********** | |
| Net Profit Before Taxes | ********** | ********** | ********** | ********** | ********** | |
| % of N.P.B.T. To Net Sales | ********** | ********** | ********** | ********** | ********** | |
| Net Profit After Taxes | ********** | ********** | ********** | ********** | ********** | |
| % of N.P.A.T. To Net Sales | ********** | ********** | ********** | ********** | ********** | |
| Debt Service Coverage Ratio | ********** | ********** | ********** | ********** | ********** | |
| Debt Service Coverage Ratio | ||||||
| Funds Available to Service Debts | ||||||
| Net Profit After Taxes | ********** | ********** | ********** | ********** | ********** | |
| Depreciation Charges | ********** | ********** | ********** | ********** | ********** | |
| Technical Knowhow Fees & Exp | ********** | ********** | ********** | ********** | ********** | |
| Interest on Long/Medium Term | ********** | ********** | ********** | ********** | ********** | |
| Total | ********** | ********** | ********** | ********** | ********** | |
| Debt Service Obligations | ||||||
| Repayment of Long/Medium Term | ********** | ********** | ********** | ********** | ********** | |
| Interest on Long/Medium Term | ********** | ********** | ********** | ********** | ********** | |
| Total | ********** | ********** | ********** | ********** | ********** | |
| ********** | ********** | ********** | ********** | ********** | ||
| D. S. C. R. (Individual) | ********** | ********** | ********** | ********** | ********** | |
| D. S. C. R. (Cumulative) | ********** | ********** | ********** | ********** | ********** | |
| D. S. C. R. (Overall) | ********** | ********** | ********** | ********** | ********** | |
| Parameters | ||||||
| Initial Equity Capital | ********** | ********** | ********** | ********** | ********** | ********** |
| Credit Balance in P & L | ********** | ********** | ********** | ********** | ********** | ********** |
| Total Capital exclUnsec Deposits | ********** | ********** | ********** | ********** | ********** | ********** |
| Unsecured Dep. | ********** | ********** | ********** | ********** | ********** | ********** |
| Total Equity incl Unsecured Deposits | ********** | ********** | ********** | ********** | ********** | ********** |
| Long/Medium Term Borrowings from Bank | ********** | ********** | ********** | ********** | ********** | ********** |
| Term lia. Incl Unsecured Deposit | ********** | ********** | ********** | ********** | ********** | ********** |
| Total Liabilities | ********** | ********** | ********** | ********** | ********** | ********** |
| Total Liabilities incl Unsecured Deposits | ********** | ********** | ********** | ********** | ********** | ********** |
| DEBT EQUITY RATIO considering | ********** | ********** | ********** | ********** | ********** | ********** |
| DEBT EQUITY RATIO considering | ||||||
| I.E.Total Term Lia./NW | ||||||
| Unsecured Dep. as Equity | ********** | ********** | ********** | ********** | ********** | ********** |
| Unsecured Dep. as Debt | ********** | ********** | ********** | ********** | ********** | ********** |
| Total Outside Lia./NW | ********** | ********** | ********** | ********** | ********** | ********** |
| Total Outside Lia./NW | ********** | ********** | ********** | ********** | ********** | |
| Assets Turnover Ratio (x) | ********** | ********** | ********** | ********** | ********** | |
| No. of Shares of 10.00 each | ********** | ********** | ********** | ********** | ********** | |
| Earnings Per Share (EPS) (in) | ********** | ********** | ********** | ********** | ********** | |
| Proposed divident | ********** | ********** | ********** | ********** | ********** | |
| Cash EPS (in) | ********** | ********** | ********** | ********** | ********** | |
| Dividend Per Share(DPS) (in) | ********** | ********** | ********** | ********** | ********** | |
| Payout Ratio (%Age) | ********** | ********** | ********** | ********** | ********** | |
| Retained Earnings/Share (in) | ********** | ********** | ********** | ********** | ********** | |
| Retained Earnings (%Age) | ********** | ********** | ********** | ********** | ********** | |
| Book Value Per Share (in) | ********** | ********** | ********** | ********** | ********** | |
| Debt Per Share (in) | ********** | ********** | ********** | ********** | ********** | |
| Probable Mkt. Price/Share(in) | ********** | ********** | ********** | ********** | ********** | |
| Price / Book Value (x) | ********** | ********** | ********** | ********** | ********** | |
| Price Earnings Ratio (x) | ********** | ********** | ********** | ********** | ********** | |
| Yield (%Age) | ********** | ********** | ********** | ********** | ********** | |
| PARTICULARS | OPERATING YEARS | |||||
|---|---|---|---|---|---|---|
| Ratio | 1-2 | 2-3 | 3-4 | 4-5 | 5-6 | |
| BREAK EVEN ANALYSIS | ||||||
| Total Value of Output | ********** | ********** | ********** | ********** | ********** | |
| Variable Cost & Expenses | ||||||
| Raw Material Cost | ********** | ********** | ********** | ********** | ********** | ********** |
| Lab & ETP Chemical Cost | ********** | ********** | ********** | ********** | ********** | ********** |
| Packing Material Cost | ********** | ********** | ********** | ********** | ********** | ********** |
| Sales Commission/Exp. | ********** | ********** | ********** | ********** | ********** | ********** |
| Sub-total | ********** | ********** | ********** | ********** | ********** | |
| Less: W.I.P. Adjustments | ********** | ********** | ********** | ********** | ********** | |
| Total Variable Cost | ********** | ********** | ********** | ********** | ********** | |
| Net Contribution | ********** | ********** | ********** | ********** | ********** | |
| Profit Volume Ratio (%) | ********** | ********** | ********** | ********** | ********** | |
| Semi-Var./Semi-Fixed Exp. | ********** | ********** | ********** | ********** | ********** | ********** |
| Miscellaneous Cost | ********** | ********** | ********** | ********** | ********** | ********** |
| Employees Expenses | ********** | ********** | ********** | ********** | ********** | ********** |
| Power/Electricity Expen | ********** | ********** | ********** | ********** | ********** | ********** |
| Fuel Expenses | ********** | ********** | ********** | ********** | ********** | ********** |
| Royalty & Other Charges | ********** | ********** | ********** | ********** | ********** | ********** |
| Repairs & Maintenance E | ********** | ********** | ********** | ********** | ********** | ********** |
| Other Mfg. Expenses | ********** | ********** | ********** | ********** | ********** | ********** |
| Administration Expenses | ********** | ********** | ********** | ********** | ********** | ********** |
| Selling Expenses | ********** | ********** | ********** | ********** | ********** | ********** |
| Interest on Wkg.Capital | ********** | ********** | ********** | ********** | ********** | ********** |
| Tot.Semi-Var./Fixed Exp. | ********** | ********** | ********** | ********** | ********** | ********** |
| Fixed Expenses / Cost | ********** | ********** | ********** | ********** | ********** | ********** |
| Miscellaneous Cost | ********** | ********** | ********** | ********** | ********** | ********** |
| Employees Expenses | ********** | ********** | ********** | ********** | ********** | ********** |
| Power/Electricity Expen | ********** | ********** | ********** | ********** | ********** | ********** |
| Fuel Expenses | ********** | ********** | ********** | ********** | ********** | ********** |
| Royalty & Other Charges | ********** | ********** | ********** | ********** | ********** | ********** |
| Repairs & Maintenance E | ********** | ********** | ********** | ********** | ********** | ********** |
| Other Mfg. Expenses | ********** | ********** | ********** | ********** | ********** | ********** |
| Administration Expenses | ********** | ********** | ********** | ********** | ********** | ********** |
| Selling Expenses | ********** | ********** | ********** | ********** | ********** | ********** |
| Intrest-Fixed Borrowing | ********** | ********** | ********** | ********** | ********** | ********** |
| Intrest-Working Capital | ********** | ********** | ********** | ********** | ********** | ********** |
| Depreciation Charges | ********** | ********** | ********** | ********** | ********** | ********** |
| Deferred Expenses W/Off | ********** | ********** | ********** | ********** | ********** | ********** |
| Total Fixed Expenses | ********** | ********** | ********** | ********** | ********** | ********** |
| Tot.Fixed/Semi-Fixed Exp | ********** | ********** | ********** | ********** | ********** | ********** |
| Tot.Cash Fixed/SemiFixed | ********** | ********** | ********** | ********** | ********** | ********** |
| Cash Break Even Sales | ********** | ********** | ********** | ********** | ********** | ********** |
| Cash Margin of Safety | ********** | ********** | ********** | ********** | ********** | ********** |
| Break Even Sales | ********** | ********** | ********** | ********** | ********** | ********** |
| Margin of safety | ********** | ********** | ********** | ********** | ********** | ********** |
| At Maximum Utilisation : | Year | ********** | ********** | ********** | ********** | ********** |
| (as % of Installed Capacity) | ||||||
| Cash B.E.P. : | % | xx% | xx% | xx% | xx% | xx% |
| B.E.P. : | % | xx% | xx% | xx% | xx% | xx% |
| MEANS OF FINANCE | |||
|---|---|---|---|
| Equity Share Capital | ********** | ********** | ********** |
| Others - Preference Share Capital | ********** | ********** | ********** |
| Total Equity Share Capital | ********** | ********** | ********** |
| ********** | ********** | ********** | |
| Long/Medium Term Borrowings | ********** | ********** | ********** |
| FROM BANK | ********** | ********** | ********** |
| From Other Financial Institutions | ********** | ********** | ********** |
| Total Long/Medium Term Borrowings | ********** | ********** | ********** |
| ********** | ********** | ********** | |
| Total Means of Finance | ********** | ********** | ********** |
| PARTICULARS | OPERATING YEARS | ||||
|---|---|---|---|---|---|
| 1-2 | 2-3 | 3-4 | 4-5 | 5-6 | |
| Equity Share Capital | ********** | ********** | ********** | ********** | ********** |
| Surplus of Previous Year | ********** | ********** | ********** | ********** | ********** |
| Add : Net Profit After Taxes | ********** | ********** | ********** | ********** | ********** |
| Surplus at the End of Year | ********** | ********** | ********** | ********** | ********** |
| Unsecured Deposits | ********** | ********** | ********** | ********** | ********** |
| Long/Medium Term Borrowings Proposed-FROM BANK | ********** | ********** | ********** | ********** | ********** |
| Bank Borrowing for Wkg. Capital | ********** | ********** | ********** | ********** | ********** |
| Current Liabilities | ********** | ********** | ********** | ********** | ********** |
| Sundry Creditors | ********** | ********** | ********** | ********** | ********** |
| Other Current Liabilities | ********** | ********** | ********** | ********** | ********** |
| Total Current Liabilities | ********** | ********** | ********** | ********** | ********** |
| ********** | ********** | ********** | ********** | ********** | |
| Total of Liabilities | ********** | ********** | ********** | ********** | ********** |
| ********** | ********** | ********** | ********** | ********** | |
| ASSETS | ********** | ********** | ********** | ********** | ********** |
| Fixed Assets | ********** | ********** | ********** | ********** | ********** |
| Gross Block | ********** | ********** | ********** | ********** | ********** |
| Less : Depreciation to Date | ********** | ********** | ********** | ********** | ********** |
| Net Block | ********** | ********** | ********** | ********** | ********** |
| Current Assets | ********** | ********** | ********** | ********** | ********** |
| Stocks on Hand | ********** | ********** | ********** | ********** | ********** |
| Receivables | ********** | ********** | ********** | ********** | ********** |
| Other Current Assets | ********** | ********** | ********** | ********** | ********** |
| Cash and Bank Balances | ********** | ********** | ********** | ********** | ********** |
| Total Current Assets | ********** | ********** | ********** | ********** | ********** |
| P & P Exp. and/or Other Dvp.Exp. | ********** | ********** | ********** | ********** | ********** |
| (To The Extent Not W/Off) | ********** | ********** | ********** | ********** | ********** |
| Other Non Current Assets | ********** | ********** | ********** | ********** | ********** |
| ********** | ********** | ********** | ********** | ********** | |
| Total of Assets | ********** | ********** | ********** | ********** | ********** |
| ROI (Average of Fixed Assets) | ********** | ********** | ********** | ********** | ********** |
| RONW (Average of Share Capital) | ********** | ********** | ********** | ********** | ********** |
| ROI (Average of Total Assets) | ********** | ********** | ********** | ********** | ********** |
INTEREST AND REPAYMENT ON TERM LOANS
| A | Name of Institution-Bank | ABC BANK | |
|---|---|---|---|
| B | Term Borrowing Amount | ********** | xx |
| C | Repayment Term (Years) | ********** | Years |
| D | Repayment Instalments | ********** | Instalments |
| E | Repayment Commencement | Year - 0; 3rd Qtr. | |
| F | Rate of Interest(General) | xxxx% | p.a. |
| G | Rate of Interest(Initial) | 0.00% | p.a. |
| H | Apply Gen. Int. Rate from Year | x Quarter :: x | |
| I | Interest Calculation | Quarterly |
| Debt Service Coverage Ratio | ||||||
|---|---|---|---|---|---|---|
| Funds Available to Service Debts | ||||||
| Net Profit After Taxes | ********** | ********** | ********** | ********** | ********** | |
| Depreciation Charges | ********** | ********** | ********** | ********** | ********** | |
| Technical Knowhow Fees & Expenses | ********** | ********** | ********** | ********** | ********** | |
| Interest on Long/Medium Term | ********** | ********** | ********** | ********** | ********** | |
| Total | ********** | ********** | ********** | ********** | ********** | |
| Debt Service Obligations | ********** | ********** | ********** | ********** | ********** | |
| Repayment of Long/Medium Term | ********** | ********** | ********** | ********** | ********** | |
| Interest on Long/Medium Term | ********** | ********** | ********** | ********** | ********** | |
| Total | ********** | ********** | ********** | ********** | ********** | |
| ********** | ********** | ********** | ********** | ********** | ||
| D. S. C. R. (Individual) | ********** | ********** | ********** | ********** | ********** | |
| D. S. C. R. (Cumulative) ..... | ********** | ********** | ********** | ********** | ********** | |
| D. S. C. R. (Overall) ........ | ********** | ********** | ********** | ********** | ********** |
DEPRECIATION CHARGES AS PER BOOKS (TOTAL)
| Operating Year | F.Assets Type A-1 | F.Assets Type A-2 | F.Assets Type B | F.Assets Type C | F.Assets Type D-1 | F.Assets Type D-2 | Total |
|---|---|---|---|---|---|---|---|
| Particulars | Factory Building | Office Buildings | Plant & Machinery | Office Vehicles | Office Automation Equipments (Telephone/ Fax/ Computer) | Furniture & Fixtures | |
| 1-2 | ********** | ********** | ********** | ********** | ********** | ********** | ********** |
| ********** | ********** | ********** | ********** | ********** | ********** | ********** | |
| ********** | ********** | ********** | ********** | ********** | ********** | ********** | |
| 2-3 | ********** | ********** | ********** | ********** | ********** | ********** | ********** |
| ********** | ********** | ********** | ********** | ********** | ********** | ********** | |
| ********** | ********** | ********** | ********** | ********** | ********** | ********** | |
| 3-4 | ********** | ********** | ********** | ********** | ********** | ********** | ********** |
| ********** | ********** | ********** | ********** | ********** | ********** | ********** | |
| ********** | ********** | ********** | ********** | ********** | ********** | ********** | |
| 4-5 | ********** | ********** | ********** | ********** | ********** | ********** | ********** |
| ********** | ********** | ********** | ********** | ********** | ********** | ********** | |
| ********** | ********** | ********** | ********** | ********** | ********** | ********** | |
| 5-6 | ********** | ********** | ********** | ********** | ********** | ********** | ********** |
| ********** | ********** | ********** | ********** | ********** | ********** | ********** | |
| ********** | ********** | ********** | ********** | ********** | ********** | ********** |
| Particulars | Method | Deprn.Rate | Part Consideration (for Asset put to use less than xx months) |
|---|---|---|---|
| Type A :: Buildings | |||
| Factory Building - | WDV | ********** | ********** |
| Office Buildings | WDV | ********** | ********** |
| Type C | |||
| Office Vehicles | WDV | ********** | ********** |
| Type D :: Misc. Fixed Assets | |||
| Office Automation Equipments (Telephone/ Fax/ Computer) | WDV | ********** | ********** |
| Furniture & Fixtures | WDV | ********** | ********** |
| Type B :: Plant & Machineries |
| Projected Pay Back Period | |||||
|---|---|---|---|---|---|
| Particulars | Operating Years | ||||
| 1-2 | 2-3 | 3-4 | 4-5 | 5-6 | |
| Year | 1 | 2 | 3 | 4 | 5 |
| Initial Investment | ********* | ||||
| Total Initial Investment | ********* | ||||
| Yearly Cash Flow | ********* | ********* | ********* | ********* | ********* |
| Accumulated Cash Flow | ********* | ********* | ********* | ********* | ********* |
| Accumulated Cash Flow | ********* | ********* | ********* | ********* | ********* |
| Pay Back Period | xx Years xx Months | xx Years xx months | |||
| Projected IRR | |||||
|---|---|---|---|---|---|
| Year | CFAT | PV factor @**% | ********* | ||
| Initial Investment | ********* | ********* | ********* | ||
| 1-2 | ********* | ********* | ********* | ||
| 2-3 | ********* | ********* | ********* | ||
| 3-4 | ********* | ********* | ********* | ||
| 4-5 | ********* | ********* | ********* | ||
| 5-6 | ********* | ********* | ********* | ||
| Total PV | ********* | ********* | |||
| IRR | ********* | ********* | |||
NIIR PROJECT CONSULTANCY SERVICES (NPCS) is a reliable name in the industrial world for offering integrated technical consultancy services. NPCS is manned by engineers, planners, specialists, financial experts, economic analysts and design specialists with extensive experience in the related industries.
Our various services are: Detailed Project Report, Business Plan for Manufacturing Plant, Start-up Ideas, Business Ideas for Entrepreneurs, Start up Business Opportunities, entrepreneurship projects, Successful Business Plan, Industry Trends, Market Research, Manufacturing Process, Machinery, Raw Materials, project report, Cost and Revenue, Pre-feasibility study for Profitable Manufacturing Business, Project Identification, Project Feasibility and Market Study, Identification of Profitable Industrial Project Opportunities, Business Opportunities, Investment Opportunities for Most Profitable Business in India, Manufacturing Business Ideas, Preparation of Project Profile, Pre-Investment and Pre-Feasibility Study, Market Research Study, Preparation of Techno-Economic Feasibility Report, Identification and Selection of Plant, Process, Equipment, General Guidance, Startup Help, Technical and Commercial Counseling for setting up new industrial project and Most Profitable Small Scale Business.
NPCS also publishes varies process technology, technical, reference, self employment and startup books, directory, business and industry database, bankable detailed project report, market research report on various industries, small scale industry and profit making business. Besides being used by manufacturers, industrialists and entrepreneurs, our publications are also used by professionals including project engineers, information services bureau, consultants and project consultancy firms as one of the input in their research.
- This report helps you to identify a profitable project for investing or diversifying into by throwing light to crucial areas like industry size, demand of the product and reasons for investing in the product.
- This report provides vital information on the product like its definition, characteristics and segmentation.
- This report helps you market and place the product correctly by identifying the target customer group of the product.
- This report helps you understand the viability of the project by disclosing details like raw materials required, manufacturing process, project costs and snapshot of other project financials.
- The report provides forecasts of key parameters which helps to anticipate the industry performance and make sound business decision.
- Our research reports broadly cover Indian markets, present analysis, outlook and forecast.
- The market forecasts are developed on the basis of secondary research and are cross-validated through interactions with the industry players.
- We use reliable sources of information and databases. And information from such sources is processed by us and included in the report.
Introduction
- Project Introduction
- Project Objective and Strategy
- Concise History of the Product
- Properties
- BIS (Bureau of Indian Standards) Provision & Specification
- Uses & Applications
Market Study and Assessment
- Current Indian Market Scenario
- Present Market Demand and Supply
- Estimated Future Market Demand and Forecast
- Statistics of Import & Export
- Names & Addresses of Existing Units (Present Players)
- Market Opportunity
Raw Material
- List of Raw Materials
- Properties of Raw Materials
- Prescribed Quality of Raw Materials
- List of Suppliers and Manufacturers
Personnel (Manpower) Requirements
- Requirement of Staff & Labor (Skilled and Unskilled) Managerial, Technical, Office Staff and Marketing Personnel
Plant and Machinery
- List of Plant & Machinery
- Miscellaneous Items
- Appliances &Equipments
- Laboratory Equipments& Accessories
- Electrification
- Electric Load & Water
- Maintenance Cost
- Sources of Plant & Machinery (Suppliers and Manufacturers)
Manufacturing Process and Formulations
- Detailed Process of Manufacture with Formulation
- Packaging Required
- Process Flow Sheet Diagram
Infrastructure and Utilities
- Project Location
- Requirement of Land Area
- Rates of the Land
- Built Up Area
- Construction Schedule
- Plant Layout and Requirement of Utilities
- Assumptions for Profitability workings
- Plant Economics
- Production Schedule
-
- Land & Building
- Factory Land & Building
- Site Development Expenses
-
- Plant & Machinery
- Indigenous Machineries
- Other Machineries (Miscellaneous, Laboratory etc.)
-
- Other Fixed Assets
- Furniture & Fixtures
- Pre-operative and Preliminary Expenses
- Technical Knowhow
- Provision of Contingencies
-
- Working Capital Requirement Per Month
- Raw Material
- Packing Material
- Lab & ETP Chemical Cost
- Consumable Store
-
- Overheads Required Per Month And Per Annum
- Utilities & Overheads (Power, Water and Fuel Expenses etc.)
- Royalty and Other Charges
- Selling and Distribution Expenses
- Salary and Wages
- Turnover Per Annum
-
- Share Capital
- Equity Capital
- Preference Share Capital
- Annexure 1:: Cost of Project and Means of Finance
-
- Annexure 2:: Profitability and Net Cash Accruals
- Revenue/Income/Realisation
- Expenses/Cost of Products/Services/Items
- Gross Profit
- Financial Charges
- Total Cost of Sales
- Net Profit After Taxes
- Net Cash Accruals
-
- Annexure 3 :: Assessment of Working Capital requirements
- Current Assets
- Gross Working. Capital
- Current Liabilities
- Net Working Capital
- Working Note for Calculation of Work-in-process
- Annexure 4 :: Sources and Disposition of Funds
-
- Annexure 5 :: Projected Balance Sheets
- ROI (Average of Fixed Assets)
- RONW (Average of Share Capital)
- ROI (Average of Total Assets)
-
- Annexure 6 :: Profitability ratios
- D.S.C.R
- Earnings Per Share (EPS)
- Debt Equity Ratio
-
- Annexure 7 :: Break-Even Analysis
- Variable Cost & Expenses
- Semi-Var./Semi-Fixed Exp.
- Profit Volume Ratio (PVR)
- Fixed Expenses / Cost
- B.E.P
-
- Annexure 8 to 11:: Sensitivity Analysis-Price/Volume
- Resultant N.P.B.T
- Resultant D.S.C.R
- Resultant PV Ratio
- Resultant DER
- Resultant ROI
- Resultant BEP
-
- Annexure 12 :: Shareholding Pattern and Stake Status
- Equity Capital
- Preference Share Capital
-
- Annexure 13 :: Quantitative Details-Output/Sales/Stocks
- Determined Capacity P.A of Products/Services
- Achievable Efficiency/Yield % of Products/Services/Items
- Net Usable Load/Capacity of Products/Services/Items
- Expected Sales/ Revenue/ Income of Products/ Services/ Items
- Annexure 14 :: Product wise domestic Sales Realisation
- Annexure 15 :: Total Raw Material Cost
- Annexure 16 :: Raw Material Cost per unit
- Annexure 17 :: Total Lab & ETP Chemical Cost
- Annexure 18 :: Consumables, Store etc.,
- Annexure 19 :: Packing Material Cost
- Annexure 20 :: Packing Material Cost Per Unit
- Annexure 21 :: Employees Expenses
- Annexure 22 :: Fuel Expenses
- Annexure 23 :: Power/Electricity Expenses
- Annexure 24 :: Royalty & Other Charges
- Annexure 25 :: Repairs & Maintenance Exp.
- Annexure 26 :: Other Mfg. Expenses
- Annexure 27 :: Administration Expenses
- Annexure 28 :: Selling Expenses
- Annexure 29 :: Depreciation Charges – as per Books (Total)
- Annexure 30 :: Depreciation Charges – as per Books (P & M)
- Annexure 31 :: Depreciation Charges - As per IT Act WDV (Total)
- Annexure 32 :: Depreciation Charges - As per IT Act WDV (P & M)
- Annexure 33 :: Interest and Repayment - Term Loans
- Annexure 34 :: Tax on Profits
- Annexure 35 ::Projected Pay-Back Period And IRR
- One Lac / Lakh / Lakhs is equivalent to one hundred thousand (100,000)
- One Crore is equivalent to ten million (10,000,000)
- T.C.I is Total Capital Investment
- We can modify the project capacity and project cost as per your requirement.
- We can also prepare project report on any subject as per your requirement.
- Caution: The project's cost, capacity and return are subject to change without any notice. Future projects may have different values of project cost, capacity or return.
Need assistance?
Share your details, we will call you
NIIR PROJECT CONSULTANCY SERVICES (NPCS) is a reliable name in the industrial world for offering integrated technical consultancy services.
Read more →Quick Links
Products & Services
Contact Info
| 106-E, Kamla Nagar,
New Delhi-110007, India. |
|
| +91 9097-075-054, +91-11-23843955, +91-11-23845886 Any quries? Call us. |
|
| [email protected]
Any quries? Mail Now. |
- Copyright © 2024 NPCS, All Right Reserved.
Let's Connect
Fill in the form below, &
we'll get back to you within 24 hours.